BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Health Issues HCR

340B Drug Pricing Program ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---Implementation of Affordable Care Act ---Program Implementation & Oversight Antibiotic & Diagnostic Tax Credit ---H.R. 3539: Antibiotic & Diagnostic Innovation Act Biodefense Research, Development and Procurement Issues (Nonfunding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2967: National Biodefense Strategy Act Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorizaton and Implementation ---Interchangeability and Pharmacy Substitution ---Naming ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 Drug Evaluation and Review ---ADAPT Act (House Discussion Draft) ---Compassionate Use/Expanded Access ---FDA Proposed Rule on Changes to Drug Labeling ---H.R. 2029: The Patient Choice Act ---H.R. 4475: Compassionate Freedom of Choice Act ---Implementation of the FDA Safety and Innovation Act ---Reauthorization of the Prescription Drug User Fee Act ---S. 2912: Trickett Wendler Right to Try Act of 2016 ---Special Medical Use/Limited Population Drugs Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Drug Manufacturing, Quality & Distribution ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Implementation of H.R. 3204: The Drug Quality and Security Act ---Pharmacy Compounding & Oversight ---Vial and Dose Size Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Centers for Disease Control and Prevention Vaccine Programs ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for FDA ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Gene Editing Technologies ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Generic Drug Entry ---S. 2615: Increasing Competition in Pharmaceuticals Act ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 Government Price Reporting ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Medicaid Pricing and Rebates ---Average Manufacturer Price Calculations ---Implementation of Affordable Care Act Reimbursement for Innovative Products ---CMMI Medicare Part B Proposed Demonstration Project ---H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare Part B Prescription Drug Models ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Value-based Contracting and Communications Senate Innovation for Healthier Americans ---Biomarkers and Regulatory Science Improvements ---Communication with Healthcare Professionals and Payors ---Expanded Access to Investigational Drugs ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---H.R. 4762: Reliable and Effective Growth for Regenerative Health Options that Improve Wellness (REGROW) Act ---Innovation Incentives ---Longitudinal Study of Chronic Diseases ---Patient Access to Approved Drugs ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---S. 195: PATH Act ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2912: Trickett Wendler Right to Try Act of 2016 ---S.524: Comprehensive Addiction and Recovery Act of 2016 ---The KIDS Act ---Use of Real-World Evidence ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---S. 1878: Advancing Hope Act of 2015 ---S.2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act Transatlantic Trade and Investment Partnership ---Intellectual Property Issues ---Regulatory Harmonization TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals Vaccine Access/Financing ---Adult Immunization (Senate Discussion Draft) ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---Implementation of Affordable Care Act ---Senate Chronic Care Working Group Proposals Vaccines and Infectious Diseases - General ---S.2512: Adding Zika Virus to the FDA Priority Review Voucher Program Act ---H.R. 5325: Continuing appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Orphan Drug Tax Credit Independent Payment Advisory Board UN High Level Commission on Access to Medicines ---Intellectual Property Provisions Sunshine Act Implementation Precision Medicine Initiative Affordable Care Act Implementation ---Third Party Support of Patient Premiums and Cost-Sharing Obligations

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Health Resources & Services Administration (HRSA); Vice President of the U.S.; Health & Human Services, Dept of (HHS); Office of Technology Policy (OTP); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); State, Dept of (DOS); Agriculture, Dept of (USDA)

Bills named: S. 2615 (114th), S. 2055 (114th), S. 1878 (114th), H.R. 3299 (114th), H.R. 2029 (114th), H.R. 5325 (114th), S. 3056 (114th), S. 2956 (114th), H.R. 3539 (114th), S. 195 (114th), H.R. 5926 (114th), S. 2912 (114th), S. 524 (114th), H.R. 4475 (114th), H.R. 5054 (114th), S. 3040 (114th), H.R. 3204 (114th), H.R. 5122 (114th), S. 2512 (114th), S. 2967 (114th), H.R. 4762 (114th)

Budget/Appropriations BUD

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Biofuels ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for 2017 ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 ---Implementation of the Agricultural Act of 2014 Funding for Centers for Disease Control and Prevention Vaccine Programs ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for FDA ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Renewable Chemicals/Bio-based Products ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Funding for the USDA ----H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Natl Economic Council (NEC); Environmental Protection Agency (EPA); Vice President of the U.S.; Office of Technology Policy (OTP); State, Dept of (DOS); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5325 (114th), S. 3000 (114th), H.R. 5054 (114th), S. 2956 (114th), H.R. 4909 (114th), S. 3040 (114th), H.R. 5293 (114th), S. 2943 (114th), H.R. 5926 (114th)

Animals ANI

Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act

Contacted: Vice President of the U.S.; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Technology Policy (OTP); Agriculture, Dept of (USDA); SENATE; Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: S. 2634 (114th), S. 2956 (114th), H.R. 5054 (114th)

Trade (domestic/foreign) TRD

Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchrony Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Intellectual Property International Enforcement ---Colombia ---Compulsory Licensing Transatlantic Trade and Investment Partnership ---Ag-Biotech Issues ---Intellectual Property Issues ---Regulatory Harmonization TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals UN High Level Commission on Access to Medicines ---Intellectual Property Provisions

Contacted: Natl Economic Council (NEC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); SENATE; Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Vice President of the U.S.; Office of Science & Technology Policy (OSTP); State, Dept of (DOS); Health Resources & Services Administration (HRSA); Office of Technology Policy (OTP); HOUSE OF REPRESENTATIVES

Bills named: S. 2956 (114th), H.R. 5054 (114th), S. 3040 (114th), H.R. 5926 (114th)

Agriculture AGR

Adventitious Presence (Low Level Presence) ---International Low Level Presence Policies Foreign Agricultural Biotechnology Laws and Regulations ---Asynchrony Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Funding for the USDA ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act Review and Labeling of Food Derived From Biotechnology ---S. 764: Senate Biotech Labeling Compromise Bill Transatlantic Trade and Investment Partnership ---Ag-Biotech Issues USDA/APHIS Agricultural Biotechnology Regulations ---Co-existence of Production Systems ---Potential Revisions to Part 340 Regulations Potential Regulation of New Genetic Modification Technologies

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Office of Technology Policy (OTP); U.S. Trade Representative (USTR); SENATE; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Vice President of the U.S.

Bills named: S. 2956 (114th), S. 764 (114th), S. 2634 (114th), H.R. 5054 (114th)

Taxation/Internal Revenue Code TAX

Antibiotic & Diagnostic Tax Credit ---H.R. 3539: Antibiotic & Diagnostic Innovation Act Biofuels (Non-Funding) ---Production Tax Credit Extension Capital Formation Investment Incentives ---H.R. 2179: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act Inversions ---Treatment of Financial Interests as Stock or Indebtedness: Section 385 Proposed Regulations Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---S. 2271: The Renewable Chemical Production Tax Credit Act ---S. 1656/H.R. 2883: Master Limited Partnership Parity Act ---Expansion of Master Limited Partnerships to Renewable Chemicals Research & Development Tax Credit Reforms ---Extension ---H.R.880: To amend the Internal Revenue Code to make permanent the credit for increasing research activities ---Permanency ---Refundable R&D Credit ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act Orphan Drug Tax Credit

Contacted: State, Dept of (DOS); Agriculture, Dept of (USDA); Natl Economic Council (NEC); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Office of Technology Policy (OTP); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Vice President of the U.S.; Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA)

Bills named: H.R. 880 (114th), H.R. 3539 (114th), S. 341 (114th), H.R. 2883 (114th), S. 1656 (114th), H.R. 3390 (114th), H.R. 2179 (114th), S. 537 (114th), S. 2271 (114th)

Copyright/Patent/Trademark CPT

Drug Patent Settlements ---S. 2019: Preserve Access to Affordable Generics Act of 2015 ---S.1137: The PATENTS Act of 2015 Intellectual Property International Enforcement ---Colombia ---Compulsory Licensing Inter Partes Review ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 ---Implementation of the America Invents Act of 2011 ---S.1137: The PATENTS Act of 2015 Patent Reform ---H.R. 9: Innovation Act ---Implementation of the America Invents Act of 2011 ---S.1137: The PATENTS Act of 2015 Transatlantic Trade and Investment Partnership ---Intellectual Property Issues TransPacific Partnership ---Data and Intellectual Property Protection for Pharmaceuticals World Trade Organization - Special 301 Submissions ---Latin American Issues UN High Level Commission on Access to Medicines ---Intellectual Property Provisions

Contacted: Agriculture, Dept of (USDA); SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Vice President of the U.S.; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); Office of Technology Policy (OTP); Natl Economic Council (NEC)

Bills named: H.R. 5485 (114th), H.R. 9 (114th), S. 1137 (114th), S. 3067 (114th), S. 2019 (114th)

Small Business SMB

Capital Formation Investment Incentives ---H.R. 2179: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act Capital Market Enhancements ---Financial CHOICE Act (House Discussion Draft) ---H.R. 3784/S.2867: Securities & Exchange Commission Small Business Advocate Act ---H.R. 4168: Small Business Capital Formation Enhancement Act ---PCAOB Audit Cost Increases Proxy Advisory Services ---Financial CHOICE Act (House Discussion Draft) ---H.R. 5311: Corporate Governance Reform and Transparency Act ---Impact of Policies on Small Public Companies Reform of SEC Regulation D ---Financial CHOICE Act (House Discussion Draft) Sarbanes Oxley Section 404 (b) ---Financial CHOICE Act (House Discussion Draft) ---H.R. 4139: Fostering Innovation Act ---PCAOB Audit Cost Increases ---Small Issuer Exemption Short Selling Transparency ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 XBRL Exemption for Small Public Companies ---Financial CHOICE Act (House Discussion Draft) ---H.R. 1965: Small Company Disclosure Simplification Act

Contacted: Vice President of the U.S.; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Office of Technology Policy (OTP); State, Dept of (DOS); Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Bills named: S. 3067 (114th), H.R. 3784 (114th), H.R. 5311 (114th), H.R. 2179 (114th), S. 537 (114th), S. 341 (114th), H.R. 1965 (114th), S. 2867 (114th), H.R. 4168 (114th), H.R. 4139 (114th), H.R. 5485 (114th)

Medicare/Medicaid MMM

Government Price Reporting ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Medicaid Pricing and Rebates ---Average Manufacturer Price Calculations ---Implementation of Affordable Care Act Reimbursement for Innovative Products ---CMMI Medicare Part B Proposed Demonstration Project ---H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare Part B Prescription Drug Models ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Value-based Contracting and Communications Senate Innovation for Healthier Americans ---Patient Access to Approved Drugs

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); Vice President of the U.S.; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); Natl Economic Council (NEC); Office of Technology Policy (OTP)

Bills named: S. 3040 (114th), H.R. 5122 (114th), H.R. 5926 (114th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---H.R. 2576: TSCA Modernization Act ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---Implementation of the Agricultural Act of 2014 ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---Nomenclature Usage ---Reauthorization of USDA Bio-Preferred Program ---S. 1656/H.R. 2883: Master Limited Partnership Parity Act ---S. 2271: The Renewable Chemical Production Tax Credit Act

Contacted: Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Vice President of the U.S.; Health Resources & Services Administration (HRSA); SENATE; Office of Technology Policy (OTP); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2576 (114th), S. 1656 (114th), S. 3000 (114th), S. 2271 (114th), H.R. 5293 (114th), H.R. 3390 (114th), H.R. 4909 (114th), H.R. 2883 (114th), S. 2943 (114th)

Consumer Issues/Safety/Products CSP

Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Interchangeability and Pharmacy Substitution ---Naming ---S.3056: Creating and Restoring Equal Access to Equivalent Samples Act of 2016 Drug Importation ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act Review and Labeling of Food Derived From Biotechnology ---S. 764: Senate Biotech Labeling Compromise Bill USDA/APHIS Agricultural Biotechnology Regulations ---Co-existence of Production Systems ---Potential Revisions to Part 340 Regulations

Contacted: Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); Health Resources & Services Administration (HRSA); State, Dept of (DOS); Office of Technology Policy (OTP); Vice President of the U.S.; Office of Management & Budget (OMB); Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: S. 3040 (114th), S. 3056 (114th), H.R. 5054 (114th), S. 764 (114th), S. 2634 (114th), H.R. 5926 (114th), S. 2956 (114th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Production Tax Credit Extension Funding for Biofuels ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 ---Implementation of the Agricultural Act of 2014 Renewable Fuel Standard ---EPA Proposed rule for the Renewable Fuel Standard Program: Standards for 2017 and Biomass-Based Diesel Volume for 2018

Contacted: Environmental Protection Agency (EPA); Natl Economic Council (NEC); State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Vice President of the U.S.; SENATE; Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Office of Technology Policy (OTP)

Bills named: H.R. 5054 (114th), H.R. 4909 (114th), H.R. 5293 (114th), S. 2956 (114th), S. 2943 (114th), S. 3000 (114th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Amendment on GE Salmon Labeling ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---Labeling ---S. 2634: The One Health Act Review and Labeling of Food Derived From Biotechnology ---S. 764: Senate Biotech Labeling Compromise Bill

Contacted: Office of Technology Policy (OTP); Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Vice President of the U.S.; SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); State, Dept of (DOS)

Bills named: S. 764 (114th), S. 2956 (114th), S. 2634 (114th), H.R. 5054 (114th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Production Tax Credit Extension Funding for Biofuels ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 ---Implementation of the Agricultural Act of 2014 Renewable Fuel Standard ---EPA Proposed rule for the Renewable Fuel Standard Program: Standards for 2017 and Biomass-Based Diesel Volume for 2018

Contacted: HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Vice President of the U.S.; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Technology Policy (OTP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Environmental Protection Agency (EPA)

Bills named: H.R. 4909 (114th), S. 3000 (114th), H.R. 5293 (114th), H.R. 5054 (114th), S. 2956 (114th), S. 2943 (114th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Nonfunding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2967: National Biodefense Strategy Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Vice President of the U.S.; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); Office of Technology Policy (OTP); Natl Economic Council (NEC); Health Resources & Services Administration (HRSA); SENATE

Bills named: H.R. 5325 (114th), H.R. 5926 (114th), H.R. 3299 (114th), S. 3040 (114th), S. 2055 (114th), S. 2967 (114th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Nonfunding) ---S. 2055/H.R. 3299: Medical Countermeasures Innovation Act of 2015 ---S. 2967: National Biodefense Strategy Act Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---H.R. 5054/S.2956: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Funding for National Institutes of Health ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 ---H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriation Act for FY 2017, and Zika Response and Preparedness Act ---Supplemental Funding for Combating Zika Gene Editing Technologies ---H.R. 5926/S.3040: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2017 Senate Innovation for Healthier Americans ---Longitudinal Study of Chronic Diseases Precision Medicine Initiative

Contacted: Environmental Protection Agency (EPA); State, Dept of (DOS); Natl Economic Council (NEC); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Technology Policy (OTP); Food & Drug Administration (FDA); Vice President of the U.S.; Health Resources & Services Administration (HRSA)

Bills named: H.R. 5926 (114th), S. 2956 (114th), S. 3040 (114th), S. 2967 (114th), H.R. 5325 (114th), H.R. 5054 (114th), S. 2055 (114th), H.R. 3299 (114th)